Literature DB >> 28429561

cfDNA screening performance: accounting for and reducing test failures.

H Cuckle1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28429561     DOI： 10.1002/uog.17492

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN： 0960-7692            Impact factor:   7.299


× No keyword cloud information.
  4 in total

1.  Audit of the first > 7500 noninvasive prenatal aneuploidy tests in a Swiss genetics center.

Authors:  Anahita Bajka; Michael Bajka; Fabian Chablais; Tilo Burkhardt
Journal:  Arch Gynecol Obstet       Date:  2021-09-17       Impact factor: 2.493

2.  Clinical performance of DNA-based prenatal screening using single-nucleotide polymorphisms approach in Thai women with singleton pregnancy.

Authors:  Tachjaree Panchalee; Naravat Poungvarin; Warisa Amornrit; Julaporn Pooliam; Pattarawalai Taluengjit; Tuangsit Wataganara
Journal:  Mol Genet Genomic Med       Date:  2020-04-24       Impact factor: 2.183

3.  Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies.

Authors:  Tianhua Huang; Clare Gibbons; Shamim Rashid; Megan K Priston; H Melanie Bedford; Ellen Mak-Tam; Wendy S Meschino
Journal:  BMC Pregnancy Childbirth       Date:  2020-11-23       Impact factor: 3.007

4.  Follow-up in Patients With Non-invasive Prenatal Screening Failures: A Reflection on the Choice of Further Prenatal Diagnosis.

Authors:  Sha Liu; Hongqian Liu; Jianlong Liu; Ting Bai; Xiaosha Jing; Tianyu Xia; Cechuan Deng; Yunyun Liu; Jing Cheng; Xiang Wei; Lingling Xing; Yuan Luo; Quanfang Zhou; Qian Zhu
Journal:  Front Genet       Date:  2021-05-19       Impact factor: 4.599
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.